These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1055260)

  • 1. Treatment of anemia in chronic hemodialysis patients.
    Wedeen RP; Lipat GA; Morse BS
    J Med Soc N J; 1975 Mar; 72(3):207-11. PubMed ID: 1055260
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of iron-dextran to replace iron losses in chronic hemodialysis patients.
    Hendler ED; Solomon L
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():108-12. PubMed ID: 756029
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
    Fishbane S; Lynn RI
    Clin Nephrol; 1995 Oct; 44(4):238-40. PubMed ID: 8575123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
    Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
    G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
    [No Abstract]   [Full Text] [Related]  

  • 5. Total dose infusion of iron dextran as a substitute for blood transfusion.
    Humphries SV
    Int Surg; 1966 Mar; 45(3):233-9. PubMed ID: 5908283
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow blood formation and iron stores in patients with chronic renal failure on maintenance hemodialysis.
    Shostka GD
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):769-77. PubMed ID: 6176500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients.
    Pitts TO; Barbour GL
    Nephron; 1978; 22(4-6):316-21. PubMed ID: 740092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].
    Duclos J; Olea C; Aguirre H; Alvarez MC; Salgado MC
    Rev Med Chil; 1995 Apr; 123(4):451-5. PubMed ID: 8525189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular iron replenishment and replacement combined with testosterone enanthate in maintenance hemodialysis anemia: a follow-up of up to 8 years on 16 patients.
    Schustack A; Meshiaj D; Waiss Z; Gotloib L
    Clin Nephrol; 1985 Jun; 23(6):303-6. PubMed ID: 4028529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histidine in the treatment of anemia in patients with chronic renal failure treated by hemodialysis].
    Rutkowski B; Góra E; Barlik J; Manitius J; Jakubowski Z
    Pol Tyg Lek; 1987 Aug; 42(34):1031-4. PubMed ID: 3422836
    [No Abstract]   [Full Text] [Related]  

  • 13. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Degree of anemia in terminal kidney insufficiency during treatment with programmed hemodialysis and blood transfusions].
    Shinkarenko NP
    Vrach Delo; 1980 Nov; (11):92-4. PubMed ID: 7467272
    [No Abstract]   [Full Text] [Related]  

  • 15. [Low doses of recombinant erythropoietin in the treatment of renal anemia in patients on chronic hemodialysis and ambulatory peritoneal dialysis].
    Lashutin SV; Nikolaev AIu; Ermolenko VM; Shutov EV; Bezruk VG; Ivashchenko MA
    Ter Arkh; 1999; 71(6):61-3. PubMed ID: 10420460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of intravenous iron dextran (Dexferrum) during hemodialysis in patients with end stage renal disease.
    Hood SA; O'Brien M; Higgins R
    Nephrol Nurs J; 2000 Feb; 27(1):41-2. PubMed ID: 10852689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of anemia in peritoneal dialysis patients.
    Lacson E; Diaz-Buxo JA
    Clin Nephrol; 2001 Dec; 56(6):415-27. PubMed ID: 11770793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and iron requirements of patients treated by maintenance hemodialysis.
    Comty CM; McDade D; Kaye M
    Trans Am Soc Artif Intern Organs; 1968; 14():426-33. PubMed ID: 5701567
    [No Abstract]   [Full Text] [Related]  

  • 19. [Parenteral iron therapy: problems and possible solutions].
    Hoigné R; Breymann C; Künzi UP; Brunner F
    Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of histidine supplementation on the anemia of uremia.
    Blumenkrantz MJ; Shapiro DJ; Swendseid ME; Kopple JD
    Proc Clin Dial Transplant Forum; 1974; (4):152-5. PubMed ID: 4468412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.